Clinical Trials
3 trialsNCT02641639 2025-03-24
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
Mateon Therapeutics
Phase 2/3 Terminated
NCT01144442 2019-07-30
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated